The endocrine disruption screening market is projected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021; it is expected to grow at a CAGR of 2.8% during 2021 to 2028.
Many chemicals, both natural and man-made, have the potential to imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been linked to developmental, reproductive, brain, immunological, and other disorders. Endocrine disruptors can be present in a variety of ordinary items, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the oestrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Endocrine Disruption Screening Market: Strategic Insights
Market Size Value in US$ 126.53 million in 2021 Market Size Value by US$ 153.30 million by 2028 Growth rate CAGR of 2.8% during 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Endocrine Disruption Screening Market: Strategic Insights
| Market Size Value in | US$ 126.53 million in 2021 |
| Market Size Value by | US$ 153.30 million by 2028 |
| Growth rate | CAGR of 2.8% during 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The growth of the endocrine disruption screening market is attributed to the growing research in the biotechnology sector and the rising prevalence of endocrine disorders. However, the high cost of screening technology hampers the market growth.
Lucrative Regions in Endocrine Disruption Screening Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Prevalence of Endocrine Disorders Drives Endocrine Disruption Screening Market
Acromegaly (overproduction of growth hormone), obesity, metabolic syndrome, impaired fasting glucose, impaired glucose tolerance, osteoporosis, osteopenia, mild-moderate hypovitaminosis D, erectile dysfunction, dyslipidemia, and thyroiditis are among the endocrine disorders that have a collective prevalence of at least 5% among the adults in the US. Of these conditions, Males have the highest incidence of erectile dysfunction, while females have the highest incidence of osteopenia/osteoporosis. Diabetes mellitus in children and pituitary adenoma are the least common conditions, affecting less than 1% of the US population. Adrenocortical carcinoma, pheochromocytoma, and pituitary adenomas are the conditions with the lowest incidence. Hyperparathyroidism and thyroid disorders are more common in women. Diabetes mellitus is most prevalent among ethnic minorities. Endocrine and metabolic diseases are among the most common modern human ailments, particularly in the US and other countries implementing ample nutrition and screening programs for high-risk individuals. Endocrine disorders such as hyperparathyroidism, primary and secondary hypogonadism, GH deficiency, and hypothyroidism can lead to other disorders, such as metabolic bone disease and diabetes mellitus. Thus, the growing prevalence and incidence of such conditions propel the demand for endocrine disruption screening products.
Assay Type-Based Insights
The endocrine disruption screening market, by assay type, is bifurcated into in-vitro and in-vivo. The in-vitro segment led the market in 2021, contributing to a market share of 64.45%, and is expected to retain its dominance during the forecast period to account for a market share of 65.73% of the overall revenue generated in 2028.
Endocrine Disruption Screening Market, by Assay Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
By application, the endocrine disruption screening market is bifurcated into natural materials and synthetic materials. In 2021, the natural materials segment held a larger share of the market. Moreover, the market for the same segment is expected to grow at a faster CAGR of 3.1% during 2021–2028.
Source of Waste-Based Insights
The endocrine disruption screening market, by source of waste, is segmented into incineration and landfill, agricultural runoff, industrial and municipal effluents, pulp mill effluents, consumer products, and others. In 2021, the incineration and landfill segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% during 2021–2028.
Method-Based Insights
The endocrine disruption screening market, by method, is segmented into estrogen receptor (ER) transactivation, androgen receptor (AR) transactivation, androgen receptor (AR) modulation, estrogen receptor-alpha (ER) binding, estrogen receptor beta (ER) binding, androgen receptor (AR) binding, steroidogenesis, aromatase assay, and others. In 2021, the estrogen receptor (ER) transactivation segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.7% from 2021 to 2028.
End-User-Based Insights
The endocrine disruption screening market, based on end use, is segmented into pharmaceutical and biopharmaceutical companies, cosmetics and household product companies, food industry, and chemical industry. In 2021, the pharmaceutical and biopharmaceutical companies segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.3% during 2021–2028.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the endocrine disruption screening market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.
The report segments endocrine disruption screening market as follows
Endocrine Disruption Screening Market – by Assay Type
- In-Vitro
- In-Vivo
Endocrine Disruption Screening Market – by Application
- Natural Materials
- Synthetic Materials
Endocrine Disruption Screening Market – by Sources of Waste
- Incineration and Landfill
- Agricultural Runoff
- Industrial and Municipal Effluents
- Pulp Mill Effluents
- Consumer Products
- Others
Endocrine Disruption Screening Market – by Method
- Estrogen Receptor (ER) Transactivation
- Androgen Receptor (AR) Transactivation
- Androgen Receptor (AR) Modulation
- Estrogen Receptor-Alpha (ER-alpha) Binding
- Estrogen Receptor Beta (ER-beta) Binding
- Androgen Receptor (AR) Binding
- Steroidogenesis
- Aromatase Assay
- Others
Endocrine Disruption Screening Market – by End User
- Pharmaceutical and Biopharmaceutical Companies
- Chemical Industry
- Food Industry
- Cosmetics and Household Product Companies
Endocrine Disruption Screening Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER LABORATORIES, INC.
- EUROFINS SCIENTIFIC Ltd.
- SMITHERS
- SGS SA
- JRF GLOBAL
- MéRIEUX NUTRISCIENCES
- ALPHA ANALYTICAL INC.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Assay Type, Application, Sources of Waste, Method, and End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Many chemicals, both natural and man-made, can imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been related to developmental, reproductive, cognitive, immunological, and other issues. Many ordinary products include endocrine disruptors, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Some hormone-disrupting compounds take a long time to degrade in the environment. As a result of this trait, they can become dangerous over time. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the estrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.
The growth of the endocrine disruption screening market is mainly attributed to factors such as the increasing prevalence of endocrine disorders coupled with rising incidence of diabetes. However, the high cost of screening technology and devices is hindering the market growth. In July 2021, DDA platform, the division of Creative Bioarray, launched a wide range of genotoxicity testing services (non-GLP) into the service segment of in vitro toxicity services which is contributing to the growth of the target market. Such strategic steps are also projected to drive the market growth.
The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market is this region is expected to grow significantly in countries such as China, Japan, South Korea, and India. The growth of the market in this region is expected to grow at a faster pace owing to factors such as high prevalence of this hormonal changes, and the rise in healthcare awareness. Additionally, developing healthcare infrastructure and increasing investments are projected to drive the Asia Pacific endocrine disruption screening market during the forecast period.
Regulatory agencies throughout the world are grappling with the task of assessing the hazards and dangers to human and ecosystem health that may come from exposure to substances that disrupt the normal functioning of endocrine systems. The rapidly rising number of compounds in commerce, along with the dependence on conventional, expensive animal tests for hazard assessment – frequently with insufficient sensitivity to many critical processes of endocrine disruption – poses persistent problems for chemical management. As a result, there are only a few compounds for which there is enough evidence to determine whether there is endocrine toxicity, and hence only a few substances with full hazard categorization. To address this issue, regulatory assessment of endocrine disrupting chemicals (EDCs) is benefiting from a toxicology revolution focused on New Approach Methodologies (NAMs) to more rapidly identify, prioritize, and assess the potential risks from chemical exposure using novel, more efficient, and mechanistically driven methodologies, and tools.
The global endocrine disruption screening market is expected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021. The market is estimated to grow with a CAGR of 2.8% from 2021-2028.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Endocrine Disruption Screening Market – By Assay Type
1.3.2 Global Endocrine Disruption Screening Market – By Application
1.3.3 Global Endocrine Disruption Screening Market – By Sources of waste
1.3.4 Global Endocrine Disruption Screening Market – By Method
1.3.5 Global Endocrine Disruption Screening Market – By End User
1.3.6 Global Endocrine Disruption Screening Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Endocrine Disruption Screening Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Endocrine Disruption Screening Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Endocrine Disorders
5.1.2 Increasing Prevalence of Diabetes
5.2 Market Restraints
5.2.1 High Cost of Screening Technology
5.3 Market Opportunities
5.3.1 Scope for Expansion in Emerging Countries
5.4 Future Trends
5.5 Regulatory Approaches for Endocrine Disrupting
5.6 Impact Analysis
6. Endocrine Disruption Screening Market– Global Analysis
6.1 Global Endocrine Disruption Screening Market Revenue Forecast and Analysis
6.2 Global Endocrine Disruption Screening Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Endocrine Disruption Screening Market Revenue and Forecasts To 2028– by Assay Type
7.1 Overview
7.2 Global Endocrine Disruption Screening Market, By Assay Type, 2021 & 2028 (%)
7.3 In-Virto
7.3.1 Overview
7.3.2 In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
7.4 In-Vivo
7.4.1 Overview
7.4.2 In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
8. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)
8.3 Natural Materials
8.3.1 Overview
8.3.2 Natural Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
8.4 Synthetic Materials
8.4.1 Overview
8.4.2 Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Sources of Waste
9.1 Overview
9.2 Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)
9.3 Incineration and landfill
9.3.1 Overview
9.3.2 Incineration and landfill: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.4 Agricultural runoff
9.4.1 Overview
9.4.2 Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.5 Industrial and Municipal Effluents
9.5.1 Overview
9.5.2 Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.6 Pulp Mill Effluents
9.6.1 Overview
9.6.2 Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.7 Consumer Products
9.7.1 Overview
9.7.2 Consumer Products: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
9.8 Others
9.8.1 Overview
9.8.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Method
10.1 Overview
10.2 Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)
10.3 Estrogen Receptor (ER) Transactivation
10.3.1 Overview
10.3.2 Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.4 Androgen Receptor (AR) Transactivation
10.4.1 Overview
10.4.2 Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.5 Androgen Receptor (AR) Modulation
10.5.1 Overview
10.5.2 Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.6 Estrogen Receptor-Alpha (ER-alpha) Binding
10.6.1 Overview
10.6.2 Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.7 Estrogen Receptor beta (ER-beta) Binding
10.7.1 Overview
10.7.2 Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.8 Androgen Receptor (AR) Binding
10.8.1 Overview
10.8.2 Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.9 Steroidogenesis
10.9.1 Overview
10.9.2 Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.10 Aromatase Assay
10.10.1 Overview
10.10.2 Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
10.11 Others
10.11.1 Overview
10.11.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – End Use
11.1 Overview
11.2 Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)
11.3 Pharmaceutical and Biopharmaceutical Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.4 Cosmetics and Household Product Companies
11.4.1 Overview
11.4.2 Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.5 Food Industry
11.5.1 Overview
11.5.2 Food Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
11.6 Chemical Industry
11.6.1 Overview
11.6.2 Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
12. Endocrine Disruption Screening Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 North America: Endocrine Disruption Screening Market
12.1.1 Overview
12.1.2 North America: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.3 North America: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)
12.1.4 North America: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)
12.1.5 North America: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)
12.1.6 North America: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)
12.1.7 North America: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)
12.1.8 North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
12.1.8.1 US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.1.1 Overview
12.1.8.1.2 US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.1.3 US: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)
12.1.8.1.4 US: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)
12.1.8.1.5 US: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)
12.1.8.1.6 US: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)
12.1.8.1.7 US: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)
12.1.8.2 Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.2.3 Canada: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)
12.1.8.2.4 Canada: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)
12.1.8.2.5 Canada: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)
12.1.8.2.6 Canada: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)
12.1.8.2.7 Canada: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)
12.1.8.3 Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
12.1.8.3.3 Mexico: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)
12.1.8.3.4 Mexico: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)
12.1.8.3.5 Mexico: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)
12.1.8.3.6 Mexico: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)
12.1.8.3.7 Mexico: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)
12.2 Europe: Endocrine Disruption Screening Market
12.2.1 Overview
12.2.2 Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.3 Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.4 Europe: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.5 Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.6 Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.7 Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8 Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
12.2.8.1 Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.3 Germany: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.4 Germany: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.1.5 Germany: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.6 Germany: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.1.7 Germany: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2 France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.1 Overview
12.2.8.2.2 France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.3 France: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.4 France: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.2.5 France: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.6 France: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.2.7 France: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3 UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.1 Overview
12.2.8.3.2 UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.3 UK: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.4 UK: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.3.5 UK: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.6 UK: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.3.7 UK: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4 Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.3 Italy: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.4 Italy: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.4.5 Italy: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.6 Italy: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.4.7 Italy: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5 Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.3 Spain: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.4 Spain: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.5.5 Spain: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.6 Spain: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.5.7 Spain: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6 Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.3 Rest of Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.4 Rest of Europe: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.2.8.6.5 Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.6 Rest of Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.2.8.6.7 Rest of Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.3.1 Overview
12.3.2 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.3 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.4 Asia Pacific: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.5 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.6 Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.7 Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.3.8.1 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.1.1 Overview
12.3.8.1.2 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.1.3 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.1.4 Japan: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.8.1.5 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.1.6 Japan: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.1.7 Japan: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.2.1 Overview
12.3.8.2.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.2.3 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type US$ Thousand)
12.3.8.2.4 China: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.8.2.5 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.2.6 China: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.2.7 China: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.3 India Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.3.1 Overview
12.3.8.3.2 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.3.3 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.3.4 India: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.8.3.5 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.3.6 India: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.3.7 India: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.4 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.4.3 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.4.4 South Korea: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.8.4.5 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.4.6 South Korea: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.4.7 South Korea: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.3.8.5.3 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.3.8.5.4 Australia: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.3.8.5.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.5.6 Australia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.5.7 Australia: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6 Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.3 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type, 2019–2028 (US$ Thousand)
12.3.8.6.4 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)
12.3.8.6.5 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.3.8.6.6 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.3.8.6.7 Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.4 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.3 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.4 Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)
12.4.5 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.6 Middle East & Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.4.7 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.4.8.1 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.1.1 Overview
12.4.8.1.2 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.1.3 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.1.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)
12.4.8.1.5 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.1.6 UAE: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.1.7 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.2.1 Overview
12.4.8.2.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.2.3 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.2.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)
12.4.8.2.5 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.2.6 Saudi Arabia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.2.7 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.3.1 Overview
12.4.8.3.2 South Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.3.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.3.4 South Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)
12.4.8.3.5 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.3.6 South Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.3.7 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.4.8.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.4.1 Overview
12.4.8.4.2 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.4.8.4.3 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.4.8.4.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)
12.4.8.4.5 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.4.8.4.6 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.4.8.4.7 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
12.5 South And Central America Endocrine Disruption Screening Market Revenue and Forecasts To 2028
12.5.1 Overview
12.5.2 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.3 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.4 South and Central America: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.5.5 South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
12.5.6 South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.5.7 South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
12.5.8.1 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.1.1 Overview
12.5.8.1.2 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.1.3 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.1.4 Argentina: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.5.8.1.5 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.1.6 Argentina: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.1.7 Argentina: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.2.1 Overview
12.5.8.2.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
12.5.8.2.3 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.2.4 Brazil: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.5.8.2.5 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.2.6 Brazil: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.2.7 Brazil: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.3 Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)
12.5.8.3.3 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
12.5.8.3.4 Rest of South & Central America: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)
12.5.8.3.5 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)
12.5.8.3.6 Rest of South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
12.5.8.3.7 Rest of South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
13. Impact Of COVID-19 Pandemic on Endocrine Disruption Screening Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Endocrine Disruption Screening Market–Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 CREATIVE BIOARRAY
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 CHARLES RIVER LABORATORIES, INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Eurofins Scientific Ltd.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 SGS SA
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 XENOMETRIX AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 SMITHERS
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 JRF Global
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Mérieux NutriSciences
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 aALPHA ANALYTICAL, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)
Table 2. North America Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 3. North America Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)
Table 4. North America Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)
Table 5. North America Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)
Table 6. US Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)
Table 7. US Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)
Table 8. US Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)
Table 9. US Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)
Table 10. US Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)
Table 11. Canada: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)
Table 12. Canada Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)
Table 13. Canada Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)
Table 14. Canada Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)
Table 15. Canada Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)
Table 16. Mexico: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)
Table 17. Mexico Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)
Table 18. Mexico Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)
Table 19. Mexico Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)
Table 20. Mexico Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)
Table 21. Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Europe: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 26. Germany: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Germany: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 28. Germany: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 29. Germany: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 30. Germany: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 31. France Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (USD Thousand)
Table 32. France: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 33. France: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 34. France: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 35. France: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 36. UK: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 37. UK: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 38. UK: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 39. UK: Endocrine Disruption Screening Market, by Method– Revenue and Forecast to 2028 (US$ Thousand)
Table 40. UK: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 41. Italy: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 42. Italy: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 43. Italy: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 44. Italy: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 45. Italy: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 46. Spain: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 47. Spain: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 48. Spain: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 49. Spain: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 50. Spain: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 51. Rest of Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 52. Rest of Europe: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 53. Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)
Table 54. Rest of Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 55. Rest of Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 56. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand).
Table 57. Asia Pacific: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 58. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 59. Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 60. Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 61. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 62. Japan: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 63. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 64. Japan: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 65. Japan: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 67. China: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 68. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 69. China: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 70. China: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 71. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 72. India: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 73. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 74. India: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 75. India: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 76. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 77. South Korea: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 78. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 79. South Korea: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 80. South Korea: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 81. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 82. Australia: Endocrine Disruption Screening Market, by Application– Revenue and Forecast to 2028 (US$ Thousand)
Table 83. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 84. Australia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 85. Australia: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 86. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)
Table 87. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)
Table 88. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 89. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 90. Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 91. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 92. Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 93. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 94. Middle East & Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 95. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 96. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 97. UAE: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 98. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 99. UAE: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 100. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 101. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 102. UAE: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 103. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 104. Saudi Arabia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 105. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 106. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 107. South Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 108. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 109. South Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 110. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 111. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 112. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 113. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 114. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 115. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)
Table 116. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 117. South and Central America: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 118. South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 119. South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 120. South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 121. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 122. Argentina: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 123. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 124. Argentina: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 125. Argentina: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 126. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 127. Brazil: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 128. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 129. Brazil: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 130. Brazil: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 131. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)
Table 132. Rest of South & Central America: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 133. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)
Table 134. Rest of South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)
Table 135. Rest of South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 136. organic Developments Done By Companies
Table 137. Inorganic Developments Done By Companies
Table 138. Glossary of Terms
LIST OF FIGURES
Figure 1. Endocrine Disruption Screening Market Segmentation
Figure 2. Endocrine Disruption Screening Market, By Region
Figure 3. Global Endocrine Disruption Screening Market Overview
Figure 4. In-Vitro Segment Held Largest Share of Assay Type Segment in Endocrine Disruption Screening Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Endocrine Disruption Screening Market, by Geography (US$ Thousand)
Figure 7. Global Endocrine Disruption Screening Market- Leading Country Markets (US$ Thousand)
Figure 8. Global Endocrine Disruption Screening Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Endocrine Disruption Screening Market
Figure 16. Global Endocrine Disruption Screening Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 17. Global Endocrine Disruption Screening Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Endocrine Disruption Screening Market
Figure 19. Global Endocrine Disruption Screening Market, by Assay Type, 2021 & 2028 (%)
Figure 20. In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 21. In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 22. Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)
Figure 23. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 24. Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 25. Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)
Figure 26. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 27. Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 28. Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 29. Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 30. Consumer Products: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 31. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 32. Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)
Figure 33. Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 34. Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 35. Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 36. Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 37. Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 38. Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 39. Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 40. Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 41. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 42. Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)
Figure 43. Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 44. Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 45. Food Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 46. Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 47. North America: Endocrine Disruption Screening Market, by Key Country – Revenue (2021) (US$ Thousands)
Figure 48. North America Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 49. North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
Figure 50. US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 51. Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 52. Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 53. Europe: Endocrine Disruption Screening Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 54. Europe: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 55. Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)
Figure 56. Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 57. France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 58. UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 59. Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 60. Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 61. Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 62. Asia Pacific Endocrine Disruption Screening Market Overview, by Country (2021)
Figure 63. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 64. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 65. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 67. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 68. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 69. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 70. Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 71. Middle East & Africa Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)
Figure 72. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 73. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 74. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 75. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 76. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 77. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 78. South and Central America Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)
Figure 79. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 80. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)
Figure 81. Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 82. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 83. Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)
Figure 84. Impact of COVID-19 Pandemic in North American Country Markets
Figure 85. Impact of COVID-19 Pandemic in European Country Markets
Figure 86. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 87. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 88. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 89. Growth Strategies Done by the Companies in the Market (%)
The List of Companies - Endocrine Disruption Screening Market
- CREATIVE BIOARRAY
- XENOMETRIX AG
- CHARLES RIVER
- EUROFINS SCIENTIFIC
- SMITHERS
- SGS SA
- JRF GLOBAL
- MéRIEUX NUTRISCIENCES
- ALPHA ANALYTICAL
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Endocrine Disruption Screening Market
Nov 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Nov 2021